Global Consumer Healthcare Market 2016-2020

消費者ヘルスケアの世界市場:市販薬、ダイエットサプリメント

◆タイトル:Global Consumer Healthcare Market 2016-2020
◆商品コード:IRTNTR8817
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年2月24日
◆ページ数:105
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、消費者ヘルスケアの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、消費者ヘルスケアの世界市場規模及び予測、製品別分析、治療クラス別分析、地域別分析/市場規模、主要国別分析、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Consumer Healthcare

The characteristics of consumer health products vary widely, with the two most important elements being the consumer needs they address and the strength of the claims made. The market for consumer-focused healthcare products is increasingly occupying the space between consumer needs and growing prevalence of lifestyle diseases. As consumer health companies develop a combination of consumer goods and pharmaceuticals, they have the ability to engage consumers by proving the clinical effectiveness of their products. These companies recognize unmet consumer needs and develop inventive ways to establish their presence in the marketplace.

Allergy care, dietary supplements, feminine care, pain relief, respiratory, and oral health are among the popular consumer health product categories. Some well-known products in the market are Voltaren and Panadol by GlaxoSmithKline; Lactacyd and Dermacyd by Sanofi; and Nexium, Advil, and Caltrate by Pfizer.

Technavio’s analysts forecast the global consumer healthcare market to grow at a CAGR of 9.26% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global consumer healthcare market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of OTC pharmaceuticals and dietary supplements.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Consumer Healthcare Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bayer HealthCare
• Boehringer Ingelheim
• GlaxoSmithKline
• Johnson & Johnson
• Pfizer
• Sanofi

[Other prominent vendors]
• Abbott Laboratories
• American Health
• Amway
• Arena Pharmaceuticals
• BASF
• BioGaia
• Bukwang Pharmaceutica
• Chr. Hansen
• Danone
• DSM
• Eisai
• EMS
• Euradite Consumer Health and Life Care
• Friggs
• Genomma Lab Internacional
• Glanbia
• Herbalife
• The Himalaya Drug Company
• Kellogg
• McNeil Consumer Healthcare
• Mead Johnson Nutrition
• Merck
• Mitsubishi Tanabe Pharma
• Nestlé
• Novartis

• Nutrition & Santé
• Omega Pharma
• Procter & Gamble
• Reckitt Benckiser
• SAVA Global
• Sigma Pharmaceuticals
• Sun Pharma
• Taisho Pharmaceuticals
• Takeda Pharmaceuticals
• Teva Pharmaceuticals
• Unifarma Global Consumer Healthcare
• Vida Laboratories
• Yakult Danone India

[Market driver]
• Awareness about lifestyle diseases
• For a full, detailed list, view our report

[Market challenge]
• Intense competition
• For a full, detailed list, view our report

[Market trend]
• Accelerated use of online resources
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Overview: Consumer healthcare market
• OTC pharmaceuticals
• Dietary supplements
• Key buying criteria
• Factors influencing go-to-market strategy

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by consumer healthcare products
• OTC pharmaceuticals
• Dietary supplements

PART 08: Geographical segmentation
• Global consumer healthcare market by geographical segmentation 2016-2020
• Consumer healthcare market in Americas
• Consumer healthcare market in APAC
• Consumer healthcare market in EMEA

PART 09: Key leading countries
• US
• China
• Japan

PART 10: Market drivers
• Awareness about lifestyle diseases
• Increase in self-medication
• Growing older population
• Rise in disposable income
• Increase in switch from prescription to OTC products

PART 11: Impact of drivers

PART 12: Market challenges
• Intense competition
• Lack of valid literature
• Adverse effects
• Counterfeit pharmaceuticals
• Stringent regulations and guidelines

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Accelerated use of online resources
• New product launches
• Promotions and marketing initiatives
• Strategic alliances

PART 15: Vendor landscape
• Competitive scenario
• Market share 2015

PART 16: Key vendor analysis
• Johnson & Johnson
• Bayer HealthCare
• GlaxoSmithKline
• Sanofi
• Pfizer
• Boehringer Ingelheim
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Types of consumer healthcare products
Exhibit 03: Key regulatory bodies that approve OTC products
Exhibit 04: FDA OTC drug approval process
Exhibit 05: Mechanisms to amend OTC drug monograph
Exhibit 06: Comparison of OTC NDA versus OTC monograph process
Exhibit 07: Strategies to establish OTC pharmaceuticals in emerging markets
Exhibit 08: Recommendation of dietary supplements by health professionals
Exhibit 09: Key buying criteria in global consumer healthcare market
Exhibit 10: Factors that influence the go-to-market strategy in global consumer healthcare market
Exhibit 11: Global consumer healthcare market 2015-2020 ($ billions)
Exhibit 12: Five forces analysis
Exhibit 13: Segmentation of global consumer healthcare market by products
Exhibit 14: Global OTC pharmaceuticals market 2015-2020 ($ billions)
Exhibit 15: Global OTC pharmaceuticals market by geography 2015
Exhibit 16: Segmentation of global OTC pharmaceuticals by therapeutic class
Exhibit 17: Global OTC pharmaceuticals market segmentation by therapeutic class 2015
Exhibit 18: Drivers and challenges of global OTC pharmaceuticals market
Exhibit 19: Global dietary supplements market 2015-2020 ($ billions)
Exhibit 20: Global dietary supplements market by geography 2015
Exhibit 21: Segmentation of global dietary supplements market by product type
Exhibit 22: Global dietary supplements market by product type 2015
Exhibit 23: Drivers and challenges of global dietary supplements market
Exhibit 24: Segmentation of global consumer healthcare market by geography 2015
Exhibit 25: Global consumer healthcare market revenue by geography 2015-2020 ($ billions)
Exhibit 26: Global consumer healthcare market revenue by geography 2015-2020
Exhibit 27: Consumer healthcare market in Americas 2015-2020 ($ billions)
Exhibit 28: Consumer healthcare market in APAC 2015-2020 ($ billions)
Exhibit 29: Consumer healthcare market in EMEA 2015-2020 ($ billions)
Exhibit 30: Key leading countries in global consumer healthcare market
Exhibit 31: Drivers and challenges
Exhibit 32: Drivers and challenges
Exhibit 33: Drivers and challenges
Exhibit 34: Impact of drivers
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Global internet penetration rate 2015
Exhibit 37: Johnson & Johnson: Business segmentation by revenue 2014
Exhibit 38: Johnson & Johnson: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
Exhibit 39: Johnson & Johnson: Consumer healthcare product categories by revenue 2014
Exhibit 40: Johnson & Johnson: YOY growth rate and revenue of OTC products 2012-2014 ($ billions)
Exhibit 41: Johnson & Johnson: YoY growth rate and revenue of skin care products 2012-2014 ($ billions)
Exhibit 42: Johnson & Johnson: YoY growth rate and revenue of baby care products 2012-2014 ($ billions)
Exhibit 43: Johnson & Johnson: YoY growth rate and revenue of oral care category 2012-2014 ($ billions)
Exhibit 44: Johnson & Johnson: YoY growth rate and revenue of wound care/other products 2012-2014 ($ billions)
Exhibit 45: Johnson & Johnson: YoY growth rate and revenue of women’s health products 2012-2014 ($ billions)
Exhibit 46: Johnson & Johnson: Geographical segmentation by consumer healthcare revenue 2014
Exhibit 47: Johnson & Johnson: SWOT analysis
Exhibit 48: Bayer HealthCare: Business segmentation by revenue 2014
Exhibit 49: Bayer HealthCare: Consumer health segmentation by revenue 2014
Exhibit 50: Bayer HealthCare: Geographic segmentation of consumer healthcare segment 2014
Exhibit 51: Bayer HealthCare: YoY growth rate and revenue of Contour 2012-2014 ($ millions)
Exhibit 52: Bayer HealthCare: YoY growth rate and revenue of Advantage 2012-2014 ($ millions)
Exhibit 53: Bayer HealthCare: YoY growth rate and revenue of Aspirin 2012-2014 ($ millions)
Exhibit 54: Bayer HealthCare: YoY growth rate and revenue of Aleve 2012-2014 ($ millions)
Exhibit 55: Bayer HealthCare: YoY growth rate and revenue of Bepanthen/Bepanthol 2012-2014 ($ millions)
Exhibit 56: Bayer Healthcare: SWOT analysis
Exhibit 57: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 58: GlaxoSmithKline: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
Exhibit 59: GlaxoSmithKline: Segmentation of consumer healthcare categories by revenue 2012-2014
Exhibit 60: GlaxoSmithKline: YoY growth rate and revenue of oral health products 2012-2014 ($ billions)
Exhibit 61: GlaxoSmithKline: YoY growth rate and revenue of wellness products 2012-2014 ($ billions)
Exhibit 62: GlaxoSmithKline: YoY growth rate and revenue of nutrition products 2012-2014 ($ millions)
Exhibit 63: GlaxoSmithKline: YoY growth rate and revenue of skin health category 2012-2014 ($ millions)
Exhibit 64: GlaxoSmithKline: Geographical segmentation by consumer health revenue 2014
Exhibit 65: GlaxoSmithKline: SWOT analysis
Exhibit 66: Sanofi: Business segmentation by revenue 2014
Exhibit 67: Sanofi: Pharmaceutical segment by revenue 2014
Exhibit 68: Sanofi: Geographical segmentation by consumer healthcare revenue 2014
Exhibit 69: Sanofi: YoY growth rate and revenue of Allegra 2012-2014 ($ millions)
Exhibit 70: Sanofi: YoY growth rate and revenue of Doliprane 2012-2014 ($ millions)
Exhibit 71: Sanofi: YoY growth rate and revenue of Essentiale 2012-2014 ($ millions)
Exhibit 72: Sanofi: YoY growth rate and revenue of Enterogermina 2012-2014 ($ millions)
Exhibit 73: Sanofi: YoY revenue comparison of Nasacort 2013 and 2014 ($ millions)
Exhibit 74: Sanofi: SWOT Analysis
Exhibit 75: Pfizer: Business segmentation by revenue 2014
Exhibit 76: Pfizer: Global vaccines, oncology, and consumer healthcare segment by revenue 2014
Exhibit 77: Pfizer: YoY growth rate and revenue of consumer healthcare category 2012-2014 ($ billions)
Exhibit 78: Pfizer: SWOT analysis
Exhibit 79: Boehringer Ingelheim: Business segmentation by revenue 2014
Exhibit 80: Boehringer Ingelheim: YoY revenue and growth rate of Buscopan 2012-2014 ($ millions)
Exhibit 81: Boehringer Ingelheim: YoY revenue and growth rate of Dulcolax 2012-2014 ($ millions)
Exhibit 82: Boehringer Ingelheim: YoY revenue and growth rate of Mucosolvan 2012-2014 ($ millions)
Exhibit 83: Boehringer Ingelheim: YoY revenue and growth rate of Pharmaton 2012-2014 ($ millions)
Exhibit 84: Boehringer Ingelheim: SWOT analysis



【掲載企業】

Bayer HealthCare, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, Abbott Laboratories, American Health, Amway, Arena Pharmaceuticals, BASF, BioGaia, Bukwang Pharmaceutica, Chr. Hansen, Danone, DSM, Eisai, EMS, Euradite Consumer Health and Life Care, Friggs, Genomma Lab Internacional, Glanbia, Herbalife, The Himalaya Drug Company, Kellogg, McNeil Consumer Healthcare, Mead Johnson Nutrition, Merck, Mitsubishi Tanabe Pharma, Nestlé, Novartis, Nutrition & Santé, Omega Pharma, Procter & Gamble, Reckitt Benckiser, SAVA Global, Sigma Pharmaceuticals, Sun Pharma, Taisho Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceuticals, Unifarma Global Consumer Healthcare, Vida Laboratories, Yakult Danone India.

【資料のキーワード】

消費者ヘルスケア、医療、市販薬、ダイエットサプリメント、医薬品、健康

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[消費者ヘルスケアの世界市場:市販薬、ダイエットサプリメント] (Global Consumer Healthcare Market 2016-2020 / IRTNTR8817)販売に関する免責事項
[消費者ヘルスケアの世界市場:市販薬、ダイエットサプリメント] (Global Consumer Healthcare Market 2016-2020 / IRTNTR8817)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆